Nicholas Muller, DPM
Foot & Ankle Surgery · Arnold, PANPI 1457880395
Payments from drug & device makers
Across 17 payments — averaging $87.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$1K
- Stryker$152
- Integra Lifesciences Corporation$36
- Zimmer Biomet$29
- Smith+Nephew$27
- Nevro Corp.$22
- plus $51 from 3 others
What the payments were for
- Travel & lodging$1,14777%
- Food & beverage$34223%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 5 | $1,172 |
| Stryker | 3 | $152 |
| Integra Lifesciences Corporation | 2 | $36 |
| Zimmer Biomet | 1 | $29 |
| Smith+Nephew | 2 | $27 |
| Nevro Corp. | 1 | $22 |
| Tactile Systems Technology Inc | 1 | $19 |
| Amgen | 1 | $16 |
| Innovation Technologies Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$1,111
How this compares
$1,488 in reported general payments places this provider in the 35th percentile of 575 foot & ankle surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 12 | $4,731 |
| Ciclopirox | 22 | $1,248 |
| Gentamicin Sulfate | 19 | $672 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 31 | $289 |
| Ketoconazole | 19 | $260 |
| Mupirocin | 33 | $233 |
| Doxycycline Hyclate | 31 | $198 |
| Terbinafine Hcl | 19 | $91 |
| Cefadroxil | 11 | $78 |
| Cephalexin | 12 | $69 |
| Silver Sulfadiazine | 15 | $45 |
| Triamcinolone Acetonide | 19 | $41 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $27 | $4,73112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 575 foot & ankle surgery providers in Pennsylvania.
Other foot & ankle surgery in Arnold
- William DecarboBelle Vernon$3.5M
- David PedowitzBryn Mawr$1.7M
- Noman SiddiquiScranton$1.3M
- Peter MangonePittsburgh$1.1M
- Stephen BrigidoBethlehem$656K
- Guido LaportaDunmore$625K
- Jason MillerMalvern$551K
- Adam TeichmanAllentown$545K
- Thomas RocchioAllentown$524K
- James SferraCranberry Township$457K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.